Search Results - Stephane Levy

Benefit–risk profile comparison between dupilumab and upadacitinib: a structured benefit–risk assessment of the Heads Up trial by Andrew Blauvelt, Eric L. Simpson, Kilian Eyerich, Marjolein de Bruin-Weller, Sebastien Barbarot, Peter A. Lio, William Hurst, Stephanie Tcherny-Lessenot, Stephane Levy, Mike Bastian

Get full text